000 | 01692 a2200505 4500 | ||
---|---|---|---|
005 | 20250514170810.0 | ||
264 | 0 | _c20041112 | |
008 | 200411s 0 0 eng d | ||
022 | _a0268-3369 | ||
024 | 7 |
_a10.1038/sj.bmt.1704442 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMohty, M | |
245 | 0 | 0 |
_aCytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen. _h[electronic resource] |
260 |
_bBone marrow transplantation _cApr 2004 |
||
300 |
_a839-46 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntigens, Viral _xblood |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
650 | 0 | 4 |
_aCytomegalovirus Infections _xetiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHLA Antigens |
650 | 0 | 4 |
_aHematologic Neoplasms _xtherapy |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xtherapy |
650 | 0 | 4 | _aSiblings |
650 | 0 | 4 |
_aTransplantation Conditioning _xmethods |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aMohty, A M | |
700 | 1 | _aBlaise, D | |
700 | 1 | _aFaucher, C | |
700 | 1 | _aBilger, K | |
700 | 1 | _aIsnardon, D | |
700 | 1 | _aSainty, D | |
700 | 1 | _aGastaut, J A | |
700 | 1 | _aViens, P | |
700 | 1 | _aOlive, D | |
700 | 1 | _aGaugler, B | |
773 | 0 |
_tBone marrow transplantation _gvol. 33 _gno. 8 _gp. 839-46 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1704442 _zAvailable from publisher's website |
999 |
_c14490990 _d14490990 |